Stockscreener 앱 받기
3.88
3.19%
0.12
시간 외 거래:
3.79
-0.09
-2.32%
전일 마감가:
$3.76
열려 있는:
$3.68
하루 거래량:
933.38K
Relative Volume:
0.68
시가총액:
$250.75M
수익:
$69.23M
순이익/손실:
$-33.10M
주가수익비율:
-3.2881
EPS:
-1.18
순현금흐름:
$-39.26M
1주 성능:
+1.84%
1개월 성능:
-20.16%
6개월 성능:
+288.00%
1년 성능:
+2.11%
1일 변동 폭
$3.5827
$4.00
1주일 범위
$3.5827
$4.00
52주 변동 폭
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
STIM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.88 | 250.75M | 69.23M | -33.10M | -39.26M | -1.18 |
|
TMO
Thermo Fisher Scientific Inc
|
421.85 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
184.96 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
406.65 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
100.26 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.22 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
Neuronetics Reports 2024 Financial Results and Strategic Advances - MSN
Transcranial Magnetic Stimulator Market to Witness Remarkable - openPR.com
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression - MSN
Even though Neuronetics (NASDAQ:STIM) has lost US$30m market cap in last 7 days, shareholders are still up 130% over 5 years - simplywall.st
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression - The Manila Times
Major Insurance Breakthrough: NeuroStar's Teen Depression Treatment Now Covered for 15 Million Lives - Stock Titan
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (NASDAQ:STIM) - Seeking Alpha
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results - The Manila Times
Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4 - Marketscreener.com
Neuronetics Updates Financial Results: Q4 Losses Deepen After Greenbrook Deal Review - Stock Titan
Transcranial Magnetic Stimulator Market Is Booming So Rapidly - openPR.com
This Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From Here - The Globe and Mail
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
While private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownership - Yahoo
Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet - Yahoo Finance
Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Transcranial Magnetic Stimulator Market Positioned - openPR
Neuronetics’ SWOT analysis: merger synergies boost growth prospects for stock - Investing.com India
Earnings call transcript: Neuronetics Q4 2024 sees revenue growth, stock rises - Investing.com Australia
Neuronetics, Inc. to Host Earnings Call - ACCESS Newswire
William Blair Increases Earnings Estimates for Neuronetics - Defense World
Neuronetics Inc (STIM) Reports 8% Revenue Growth in Q3 2023 - GuruFocus.com
Neuronetics CFO Stephen Furlong sells $8,364 in stock - Investing.com India
Neuronetics (NASDAQ:STIM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
(STIM) Technical Data - news.stocktradersdaily.com
Neuronetics executive sells shares worth $1,688 By Investing.com - Investing.com Canada
Neuronetics executive sells shares worth $1,688 - Investing.com India
Neuronetics CFO Stephen Furlong sells $8,364 in stock By Investing.com - Investing.com UK
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 69% Yet They're Still Not Telling The Full Story - Simply Wall St
Transcranial Magnetic Stimulator Market Growth and Future - openPR
Neuronetics’ Earnings Call: Growth Amid Challenges - TipRanks
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call Transcript - MSN
Neuronetics stock holds Market Outperform amid merger growth By Investing.com - Investing.com Canada
Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... By GuruFocus - Investing.com Canada
Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... - Yahoo Finance
Neuronetics’ Strategic Merger with Greenbrook TMS Fuels Growth and Positive Outlook - TipRanks
Neuronetics Reports Growth Amid Strategic Acquisitions - TipRanks
Canaccord raises Neuronetics stock target to $8, maintains buy rating By Investing.com - Investing.com Australia
Canaccord raises Neuronetics stock target to $8, maintains buy rating - Investing.com India
Neuronetics stock soars to 52-week high, hits $5.08 By Investing.com - Investing.com Canada
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
자본화:
|
볼륨(24시간):